603987.SHG Shanghai Kindly Entrp Dvlp Grp
- Market cap
- CNY 3.18B
- P/E
- 14.3x
- P/B
- 1.09x
- ROE
- 8.0%
- Dividend yield
- 2.62%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603987.SHG undervalued?
Graham number603987.SHG trades 17.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai Kindly Entrp Dvlp Grp fundamental analysis
No fundamental analysis for Shanghai Kindly Entrp Dvlp Grp yet.
Shanghai Kindly Entrp Dvlp Grp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai Kindly Entrp Dvlp Grp
Shanghai Kindly Enterprise Development Group Co.,LTD. researches, develops, produces, sells, medical devices such as medical puncture needles and medical infusion devices worldwide. It offers syringes, infusion sets, needles, and tube bags. The company also provides medical packing films, sterilization indicator tapes and needles; and intervention accessories, such as stopcocks. In addition, it offers disposable coaxial biopsy needle, therapy device, disposable pump infusion…
Full company profileShanghai Kindly Entrp Dvlp Grp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai Kindly Entrp Dvlp Grp annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.13B | 1.26B | 1.45B | 1.82B | 2.65B | 3.10B | 3.12B | 2.45B | 2.26B | 2.30B | 2.26B |
| Gross Profit | 373M | 420M | 505M | 687M | 987M | 1.19B | 1.04B | 794M | 726M | 760M | 704M |
| Operating Income | 138M | 161M | 201M | 282M | 380M | 478M | 399M | 301M | 255M | 291M | 265M |
| EBITDA | 229M | 244M | 281M | 390M | 525M | 636M | 566M | 474M | 423M | 482M | 298M |
| Net Income | 101M | 119M | 147M | 170M | 203M | 291M | 312M | 231M | 215M | 240M | 231M |
| EPS | 0.29 | 0.27 | 0.33 | 0.39 | 0.46 | 0.66 | 0.71 | 0.53 | 0.49 | 0.55 | 0.53 |
| Balance Sheet | |||||||||||
| Total Assets | 1.55B | 1.60B | 2.17B | 3.77B | 4.26B | 4.96B | 4.14B | 4.22B | 4.15B | 4.19B | 4.37B |
| Total Liabilities | 319M | 261M | 546M | 1.07B | 1.29B | 1.57B | 1.59B | 1.44B | 1.24B | 1.14B | 1.21B |
| Shareholders' Equity | 1.14B | 1.23B | 1.37B | 1.60B | 1.76B | 2.08B | 2.23B | 2.41B | 2.54B | 2.72B | 2.89B |
| Cash & Short-term Investments | 357M | 351M | 727M | 1.11B | 1.28B | 1.01B | 423M | 511M | 368M | 492M | 549M |
| Total Debt | 101M | 1.30M | 203M | 461M | 566M | 698M | 777M | 765M | 572M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 235M | 183M | 314M | 256M | 403M | 409M | 462M | 450M | 292M | 408M | - |
| Capital Expenditure | 75.7M | 125M | 180M | 219M | 332M | 654M | 296M | 228M | 144M | 147M | 47.0M |
| Free Cash Flow | 159M | 58.7M | 134M | 37.4M | 71.1M | -245M | 165M | 212M | 149M | 261M | 198M |
| Ratios | |||||||||||
| ROE | 8.8% | 9.7% | 10.7% | 10.6% | 11.5% | 14.0% | 14.0% | 9.6% | 8.5% | 8.9% | 8.0% |
| ROA | 6.5% | 7.4% | 6.8% | 4.5% | 4.8% | 5.9% | 7.5% | 5.5% | 5.2% | 5.7% | 5.3% |
| Net Profit Margin | 8.9% | 9.5% | 10.1% | 9.4% | 7.7% | 9.4% | 10.0% | 9.4% | 9.5% | 10.5% | 10.2% |
| Debt to Equity | 0.09x | 0.00x | 0.15x | 0.29x | 0.32x | 0.34x | 0.35x | 0.32x | 0.23x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shanghai Kindly Entrp Dvlp Grp dividends
- Dividend yield
- 2.62%
- Forward dividend
- 0.17 CNY
- Payout ratio
- 34.6%
- Ex-dividend date
- Jun 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 83.1M | 0.19 | 34.6% |
| 2024 | CNY 94.0M | 0.21 | 43.7% |
| 2023 | CNY 123M | 0.28 | 53.2% |
| 2022 | CNY 135M | 0.31 | 43.5% |
| 2021 | CNY 24.6M | 0.06 | 8.4% |
| 2020 | CNY 65.4M | 0.15 | 32.2% |
| 2019 | CNY 66.2M | 0.15 | 38.9% |
| 2018 | CNY 47.6M | 0.11 | 32.3% |
| 2017 | CNY 33.7M | 0.08 | 28.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jul 18, 2018.
Who owns Shanghai Kindly Entrp Dvlp Grp
- Insiders 44.90%
- Institutions 1.26%
- Public & others 53.84%
- Shares outstanding 437M
- Free float 250M
Shanghai Kindly Entrp Dvlp Grp company profile
- Company name
- Shanghai Kindly Entrp Dvlp Grp
- Ticker
- 603987.SHG
- ISIN
- CNE100003076
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 3,495
- Fiscal year end
- December
- Address
- Building 1, No. 658 Gaochao Road, Shanghai, China, 201803
- Phone
- 86 21 6911 9653
- Website
- kdlchina.cn
About Shanghai Kindly Entrp Dvlp Grp
Shanghai Kindly Enterprise Development Group Co.,LTD. researches, develops, produces, sells, medical devices such as medical puncture needles and medical infusion devices worldwide. It offers syringes, infusion sets, needles, and tube bags. The company also provides medical packing films, sterilization indicator tapes and needles; and intervention accessories, such as stopcocks. In addition, it offers disposable coaxial biopsy needle, therapy device, disposable pump infusion sets, pharmaceutical packaging materials, drug liquid transfer devices, needle-proof prefilled syringe assemblies, polypropylene prefilled injection, disposable water delivery tube, indwelling needles, disposable anti-needle injection and pen needle, micro needle, disposable skin-penetrating guide needles and syringes, radiofrequency treatment puncture needle, visual double-lumen endotracheal tube, disposable reflux indwelling needle, root irrigation needle, disposable arterial blood gas needle, compression hemostatic device. Further, it offers puncture care, infusion catheters, indwelling infusions, puncture intervention, medical beauty, and medicine bags. The company exports its products to the United States, Europe, South America, the Middle East, Southeast Asia, and internationally. The company is headquartered in Shanghai, China.
Shanghai Kindly Entrp Dvlp Grp management
5- Mr. Wei Xin ZhangGM & Director · born 1973
- Mr. Jian Yong XiangVice Chairman & Deputy GM · born 1974
- Mr. Xiaoru ShenCFO, Financial Director & Accounting Supervisor · born 1984
- Mr. Yong ZhangDeputy GM & Director · born 1971
- Ms. Gu JiajunBoard Secretary · born 1985